24 drugs will be included in the Shanghai ** reimbursement list

At present, Shanghai has included 24 drugs in the Medicare reimbursement list. These varieties are national drug price negotiating drugs and some cancer molecular targeted drugs, and will be implemented as of January 1, 2017.

This part of the drug implementation of "set the hospital, set the doctor, set the indication" of "three set" management. Fixed-point medical institutions must be equipped with a team of clinical pharmacists to participate in the management of drug use; the use of molecular targeted drugs for cancer is limited to the qualification for registration of major medical care for malignant tumors (chemotherapy, radiation therapy, isotope therapy, interventional therapy, and Chinese medicine treatment), and principles There should be a medical institution with genetic testing capabilities.

A doctor who prescribes a molecular-targeted drug for oncology must refer the above-mentioned physicians to the relevant clinical department. The specific list is determined by each designated medical institution and reported to the municipal medical insurance management center for the record.

Employee basic medical insurance, medical insurance for small cities and towns and outpatients use molecular targeted drugs in some drugs, and is included in the "registration management" of outpatients with major diseases, limited to the treatment of malignant tumors (chemotherapy, radiation therapy, isotope therapy, interventional therapy, traditional Chinese medicine Treatment) Major illness Registered at the same designated medical institution.

The centralized procurement of some medicines is the responsibility of the Municipal Bureau of Medicine's centralized tendering and procurement management. The determined purchase price is the purchase price of the medical insurance agreement, and it is pushed to all fixed points through the municipal pharmaceutical centralized procurement service and supervision information system (“Sunshine Platform”). Medical institutions.